Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis 2
2016-002075-10Phase 3Unknown
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of tenecteplase in brain infarction and ischemic stroke (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Functional outcome at day 90 (modified Rankin Scale distribution). Status: unknown.
02
Drugs
tenecteplase
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on 2016-002075-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002075-10.